Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 2 Solid Tumors 1 Ovarian Neoplasms 1 Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Advanced Cancers 1

Interventions

temsirolimus 1 ridaforolimus 1 pazopanib 1 Surveys and Questionnaires 1 Pemetrexed 1 Lenalidomide 1 Crizotinib 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Advanced Cancers × ridaforolimus × Clear all

NCT00836927 2019-02-18

MK-8669-038

Merck Sharp & Dohme LLC

Phase 2 Terminated

7 enrolled 13 charts

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡